Franklin Resources’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27M Sell
409,784
-206
-0.1% -$13.1K 0.01% 868
2025
Q4
$26.1M Buy
409,990
+265
+0.1% +$16.5K 0.01% 869
2025
Q3
$22.5M Buy
409,725
+6,936
+2% +$286K 0.01% 915
2025
Q2
$13.3M Sell
402,789
-134,835
-25% -$4.69M ﹤0.01% 1043
2025
Q1
$21.6M Sell
537,624
-8,189
-2% -$376K 0.01% 882
2024
Q4
$25.7M Buy
545,813
+9,366
+2% +$486K 0.01% 826
2024
Q3
$29.2M Buy
536,447
+132,886
+33% +$7.41M 0.01% 769
2024
Q2
$21.9M Sell
403,561
-161,735
-29% -$9.76M 0.01% 828
2024
Q1
$39.6M Sell
565,296
-95,386
-14% -$7.38M 0.01% 645
2023
Q4
$55.2M Sell
660,682
-470,406
-42% -$17M 0.03% 472
2023
Q3
$33.3M Buy
1,131,088
+10,903
+1% +$363K 0.02% 609
2023
Q2
$36.5M Buy
1,120,185
+35,541
+3% +$1.31M 0.02% 614
2023
Q1
$38.2M Sell
1,084,644
-21,396
-2% -$873K 0.02% 612
2022
Q4
$50.7M Sell
1,106,040
-2,232
-0.2% -$96K 0.03% 526
2022
Q3
$53.7M Buy
1,108,272
+14,692
+1% +$707K 0.03% 499
2022
Q2
$43M Buy
1,093,580
+1,708
+0.2% +$68.8K 0.02% 583
2022
Q1
$40.2M Buy
1,091,872
+52,799
+5% +$1.88M 0.02% 659
2021
Q4
$47.4M Buy
1,039,073
+39,026
+4% +$1.51M 0.02% 651
2021
Q3
$35.7M Buy
+1,000,047
New +$29.4M 0.01% 748

Other funds holding CYTK